MAPS — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-06

• •Cash and cash equivalents totaled $60.5 million as of June 30, 2026 as compared to $62.4 million as of December 31, 2025.

• spend declines in established markets driven by continued industry challenges, such as price deflation and ongoing consolidation, partially offset by a positive mixed impact from churn among clients with below-average spend levels.

• Net income for the three months ended June 30, 2026 and 2025 was $2.9 million and $2.2 million, respectively. The increase in net income was primarily due to a decrease in total costs and expenses of $2.9 million and change in tax receivable agreement (“TRA”) liability of $0.5 million, partially off…

• Net income for the six months ended June 30, 2026 was $4.6 million compared with a net income for the six months ended June 30, 2025 of $4.7 million. The changes in net income were primarily due to a decrease in total costs and expenses of $1.5 million, change in TRA liability of $1.1 million and an…

• To provide investors with additional information regarding our financial results, we have disclosed EBITDA and Adjusted EBITDA, both of which are non-GAAP financial measures that we calculate as net income before interest, taxes and depreciation and amortization expense in the case of EBITDA and fur…

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• •Cash, cash equivalents and marketable securities totaled $57.0 million as of March 31, 2026.

• paying client for the three months ended March 31, 2026 compared to the same period in 2025 was primarily due to a positive mix impact from churn among clients with below-average spend levels.

• Net income for the three months ended March 31, 2026 was $1.7 million compared to $2.5 million for the three months ended March 31, 2025. The decrease in net income was primarily due to a decrease in revenue of $1.1 million, an increase in operating expenses of $1.4 million, partially offset by an i…

• To provide investors with additional information regarding our financial results, we have disclosed EBITDA and Adjusted EBITDA, both of which are non-GAAP financial measures that we calculate as net income before interest, taxes and depreciation and amortization expense in the case of EBITDA and fur…

• We believe that we will have significant opportunities for greater growth as more jurisdictions legalize cannabis for medical and/or adult-use and the regulatory environment continues to develop. Currently, forty states, the District of Columbia, Puerto Rico, the Virgin Islands, Guam and the Norther…

Text added vs the prior filing · source: 10-Q · 2026-08-06

• over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

• Under the supervision of and with the participation of our management, we assessed the effectiveness of our internal control over financial reporting as of June 30, 2026, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control —…

• had not yet been fully implemented or had not been in place for a sufficient period of time to demonstrate that they were having their desired effect:

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• Under the supervision of and with the participation of our management, we assessed the effectiveness of our internal control over financial reporting as of March 31, 2026, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control …

• reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

• •Commencing configuration of our new ERP system, which will replace our legacy ERP system in the fiscal year ending December 31, 2026.